StockData
Ocean Biomedical, Inc. logo

Ocean Biomedical, Inc. (OCEA) stock

OCEAOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q1 FY2025, quarter ended Mar 31, 2025Last filing: 10-Q on May 15, 2025
$0.00−0.00 (-16.67%)

Close on Oct 19, 2026Market cap $45.51KP/E –Yield –

Ocean Biomedical r&d expenses

Research and development expenses are spending on new products and technology.

Ocean Biomedical's R&D Expenses for the twelve months ending Mar 31, 2025 was $18.00K. For fiscal 2024 it was $26.00K, down 96.3% from the year before.

Annual r&d expenses

PeriodPeriod endValueChange
FY2024Dec 31, 2024$26.00K-96.3%
FY2023Dec 31, 2023$709.00K-91.6%
FY2022Dec 31, 2022$8.41M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2025Mar 31, 2025$18.00K-30.8%
Q4 FY2024Dec 31, 2024$0-100.0%
Q3 FY2024Sep 30, 2024$0-100.0%
Q2 FY2024Jun 30, 2024$0-100.0%
Q1 FY2024Mar 31, 2024$26.00K-83.9%
Q3 FY2023Sep 30, 2023$305.00K-83.6%
Q2 FY2023Jun 30, 2023$28.00K-99.1%
Q1 FY2023Mar 31, 2023$393.00K-87.7%
Q4 FY2022Dec 31, 2022$161.00K–
Q3 FY2022Sep 30, 2022$1.86M–
Q2 FY2022Jun 30, 2022$3.19M–
Q1 FY2022Mar 31, 2022$3.20M–

More Ocean Biomedical figures

See a number that looks wrong?